Refractory Neuroblastoma

DrugDrug NameDrug Description
DB00853TemozolomideAn alkylating agent used to treat glioblastoma multiforme and refractory anaplastic astrocytoma.
DB01030TopotecanAn antineoplastic agent used to treat ovarian cancer, small cell lung cancer, or cervical cancer.
DrugDrug NamePhaseStatusCount
DB00531Cyclophosphamide1Recruiting1
DB09077Dinutuximab1Active Not Recruiting1
DB01073Fludarabine1Recruiting1
DB00982Isotretinoin1Active Not Recruiting1
DB00480Lenalidomide1Active Not Recruiting1
DB00755Tretinoin1Active Not Recruiting1
DB04690Camptothecin1 / 2Recruiting1
DB08865Crizotinib1 / 2Completed1
DB06186Ipilimumab1 / 2Recruiting1
DB00762Irinotecan1 / 2Recruiting1
DB11740MK-17751 / 2Recruiting1
DB09035Nivolumab1 / 2Recruiting1
DB00135Tyrosine1 / 2Completed1
DB09077Dinutuximab2Recruiting1
DB06243Eflornithine2Recruiting1
DB14860Ensartinib2Recruiting2
DB12147Erdafitinib2Recruiting2
DB15127Hydrogen2Recruiting1
DB15127Hydrogen2Suspended1
DB00762Irinotecan2Recruiting1
DB12167LY-30234142Recruiting2
DB14723Larotrectinib2Recruiting2
DB09074Olaparib2Recruiting2
DB09073Palbociclib2Recruiting2
DB00020Sargramostim2Recruiting1
DB11689Selumetinib2Recruiting1
DB11689Selumetinib2Suspended1
DB14546Sulfate ion2Recruiting2
DB14546Sulfate ion2Suspended1
DB12887Tazemetostat2Recruiting2
DB00853Temozolomide2Recruiting1
DB13930Ulixertinib2Recruiting2
DB08881Vemurafenib2Recruiting2
DB13104X-3962Recruiting2